×

Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

  • US 8,288,384 B2
  • Filed: 11/16/2009
  • Issued: 10/16/2012
  • Est. Priority Date: 12/28/2006
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating Type II diabetes, said method comprising administering to a subject in need of such treatment an effective amount of a compound that is that is 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine or a pharmaceutically acceptable salt thereof.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×